Your browser doesn't support javascript.
loading
India Hypertension Control Initiative-Hypertension treatment and blood pressure control in a cohort in 24 sentinel site clinics.
Kaur, Prabhdeep; Kunwar, Abhishek; Sharma, Meenakshi; Mitra, Jhilam; Das, Chinmoyee; Swasticharan, Leimapokpam; Chakma, Tapas; Dipak Bangar, Sampada; Venkatasamy, Vettrichelvan; Dharamsoth, Raviteja; Purohit, Saurabh; Tayade, Sadhana; Singh, Gurinder B; Bitragunta, Sailaja; Durgad, Kiran; Das, Bidisha; Dar, Sunil; Bharadwaj, Rupali; Joshi, Chakshu; Bharadwaj, Vishwajit; Khedkar, Suhas; Chenji, Sravan; Reddy, Sravan K; Sreedhar, Chintala; Parasuraman, Ganeshkumar; Kasiviswanathan, Savitha; Viswanathan, Vidhya; Uike, Pankaj; Gaigaware, Pooja; Yadav, Suniti; Dhaliwal, R S; Ramakrishnan, Sivasubramanian; Tullu, Fikru T; Bhargava, Balram.
Afiliação
  • Kaur P; ICMR-National Institute of Epidemiology, Chennai, India.
  • Kunwar A; WHO Country Office for India, New Delhi, India.
  • Sharma M; Indian Council of Medical Research (ICMR), New Delhi, India.
  • Mitra J; ICMR-National Institute of Epidemiology, Chennai, India.
  • Das C; Directorate General of Health Services I Ministry of Health and Family Welfare, New Delhi, India.
  • Swasticharan L; Directorate General of Health Services I Ministry of Health and Family Welfare, New Delhi, India.
  • Chakma T; ICMR-National Institute of Research in Tribal Health, Jabalpur, India.
  • Dipak Bangar S; ICMR-National AIDS Research Institute, Pune, India.
  • Venkatasamy V; ICMR-National Institute of Epidemiology, Chennai, India.
  • Dharamsoth R; State NCD Cell, Department of Health, Medical and Family Welfare, Govt of Telangana, Hyderabad, India.
  • Purohit S; State NCD Cell, Directorate of Health Services, Govt of Madhya Pradesh, Bhopal, India.
  • Tayade S; State NCD Cell, Directorate of Health Services, Govt of Maharashtra, Mumbai, India.
  • Singh GB; State NCD Cell, Department of Health and Family Welfare, Govt of Punjab, Chandigarh, India.
  • Bitragunta S; ICMR-National Institute of Epidemiology, Chennai, India.
  • Durgad K; WHO Country Office for India, New Delhi, India.
  • Das B; WHO IHCI Project, Punjab, India.
  • Dar S; WHO IHCI Project, Punjab, India.
  • Bharadwaj R; WHO IHCI Project, Madhya Pradesh, India.
  • Joshi C; WHO IHCI Project, Madhya Pradesh, India.
  • Bharadwaj V; WHO IHCI Project, Maharashtra, India.
  • Khedkar S; WHO IHCI Project, Maharashtra, India.
  • Chenji S; WHO IHCI Project, Telangana, India.
  • Reddy SK; WHO IHCI Project, Telangana, India.
  • Sreedhar C; WHO IHCI Project, Telangana, India.
  • Parasuraman G; ICMR-National Institute of Epidemiology, Chennai, India.
  • Kasiviswanathan S; ICMR-National Institute of Epidemiology, Chennai, India.
  • Viswanathan V; ICMR-National Institute of Epidemiology, Chennai, India.
  • Uike P; ICMR-National Institute of Research in Tribal Health, Jabalpur, India.
  • Gaigaware P; ICMR-National AIDS Research Institute, Pune, India.
  • Yadav S; Indian Council of Medical Research (ICMR), New Delhi, India.
  • Dhaliwal RS; Indian Council of Medical Research (ICMR), New Delhi, India.
  • Ramakrishnan S; All India Institute of Medical Sciences, New Delhi, India.
  • Tullu FT; WHO Country Office for India, New Delhi, India.
  • Bhargava B; Indian Council of Medical Research (ICMR), New Delhi, India.
J Clin Hypertens (Greenwich) ; 23(4): 720-729, 2021 04.
Article em En | MEDLINE | ID: mdl-33369074
ABSTRACT
The India Hypertension Control Initiative (IHCI) is a multi-partner initiative, implementing and scaling up a public health hypertension control program across India. A cohort of 21,895 adult hypertension patients in 24 IHCI sentinel site facilities in four Indian states (Punjab, Madhya Pradesh, Maharashtra, and Telangana), registered from January 2018 until June 2019 were assessed at baseline and then followed up for blood pressure (BP) control and antihypertensive medication use. Among all registrations, 11 274 (51%) of the patients returned for a follow-up visit between July 2019 and September 2019. Among patients returning for follow-up, 26.3% had BP controlled at registration, and 59.8% had BP controlled at follow-up (p < .001). The absolute improvement in BP control was more than two times greater in primary care (48.1 percentage point increase) than secondary care facilities (22.9 percentage point increase). Most IHCI patients received prescriptions according to state-specific treatment protocols. This study demonstrates that a scalable public health hypertension control program can yield substantial BP control improvements, especially in primary care settings. However, high loss to follow-up limits population health impact; future efforts should focus on improving systems to increase the likelihood that patients will return to the clinic for routine hypertension care.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Hipertensão Tipo de estudo: Diagnostic_studies / Guideline / Risk_factors_studies Limite: Adult / Humans País/Região como assunto: Asia Idioma: En Revista: J Clin Hypertens (Greenwich) Assunto da revista: ANGIOLOGIA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Índia

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Hipertensão Tipo de estudo: Diagnostic_studies / Guideline / Risk_factors_studies Limite: Adult / Humans País/Região como assunto: Asia Idioma: En Revista: J Clin Hypertens (Greenwich) Assunto da revista: ANGIOLOGIA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Índia